AU2002356323A8 - Cancer-specific mutants of b-raf genes and uses thereof - Google Patents
Cancer-specific mutants of b-raf genes and uses thereofInfo
- Publication number
- AU2002356323A8 AU2002356323A8 AU2002356323A AU2002356323A AU2002356323A8 AU 2002356323 A8 AU2002356323 A8 AU 2002356323A8 AU 2002356323 A AU2002356323 A AU 2002356323A AU 2002356323 A AU2002356323 A AU 2002356323A AU 2002356323 A8 AU2002356323 A8 AU 2002356323A8
- Authority
- AU
- Australia
- Prior art keywords
- cancer
- specific mutants
- raf genes
- raf
- genes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34468401P | 2001-12-24 | 2001-12-24 | |
| US60/344,684 | 2001-12-24 | ||
| PCT/GB2002/005921 WO2003060111A2 (en) | 2001-12-24 | 2002-12-24 | Cancer-specific mutants of b-raf genes and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002356323A1 AU2002356323A1 (en) | 2003-07-30 |
| AU2002356323A8 true AU2002356323A8 (en) | 2003-07-30 |
Family
ID=23351558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002356323A Abandoned AU2002356323A1 (en) | 2001-12-24 | 2002-12-24 | Cancer-specific mutants of b-raf genes and uses thereof |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002356323A1 (en) |
| WO (1) | WO2003060111A2 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE556713T1 (en) | 1999-01-13 | 2012-05-15 | Bayer Healthcare Llc | OMEGA-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS P38 KINASE INHIBITORS |
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US7838541B2 (en) | 2002-02-11 | 2010-11-23 | Bayer Healthcare, Llc | Aryl ureas with angiogenesis inhibiting activity |
| PT1626714E (en) | 2003-05-20 | 2007-08-24 | Bayer Pharmaceuticals Corp | Diaryl ureas for diseases mediated by pdgfr |
| BR122016015715B8 (en) | 2003-07-23 | 2021-05-25 | Bayer Healthcare Llc | pharmaceutical compositions of 4[4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy)-pyridine-2-carboxylic acid methylamide |
| WO2013109142A1 (en) | 2012-01-16 | 2013-07-25 | Stichting Het Nederlands Kanker Instituut | Combined pdk and mapk/erk pathway inhibition in neoplasia |
| WO2015041533A1 (en) | 2013-09-20 | 2015-03-26 | Stichting Het Nederlands Kanker Instituut | Rock in combination with mapk-pathway |
| WO2015041534A1 (en) | 2013-09-20 | 2015-03-26 | Stichting Het Nederlands Kanker Instituut | P90rsk in combination with raf/erk/mek |
-
2002
- 2002-12-24 AU AU2002356323A patent/AU2002356323A1/en not_active Abandoned
- 2002-12-24 WO PCT/GB2002/005921 patent/WO2003060111A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003060111A2 (en) | 2003-07-24 |
| AU2002356323A1 (en) | 2003-07-30 |
| WO2003060111A3 (en) | 2004-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1436385A4 (en) | Dna polymerases and mutants thereof | |
| EP1390468A4 (en) | Identification of essential genes of aspegillus fumigatus and methods of use | |
| AU7798201A (en) | Elongase genes and uses thereof | |
| AU2002258790A1 (en) | Novel microarrays and methods of use thereof | |
| HK1043150A1 (en) | Human delta 5-desaturase gene and uses thereof | |
| HUP0401017A3 (en) | Combination of probiotics | |
| EP1399460A4 (en) | Breast cancer-associated genes and uses thereof | |
| EP1290005A4 (en) | Vegf-modulated genes and methods employing them | |
| AU2002314466A1 (en) | Withasol and methods of use | |
| AU2002329759A1 (en) | Methyltransferase genes and uses thereof | |
| EP1373483A4 (en) | Mono- and diacylglycerol acyltransferases and methods of use thereof | |
| EP1392106A4 (en) | Tyra genes and uses thereof | |
| AU2002335085A1 (en) | Angiopoietins and methods of use thereof | |
| AU2002353095A8 (en) | Streptavidin expressed gene fusions and methods of use thereof | |
| AU2002350332A1 (en) | Methods of parallel gene cloning and analysis | |
| IL160772A0 (en) | Pancreatic smal cells and uses thereof | |
| EP1373285A4 (en) | Synthesis and use of glycodendrimer reagents | |
| AU2002356323A8 (en) | Cancer-specific mutants of b-raf genes and uses thereof | |
| EP1456418A4 (en) | Identification of novel polymorphic sites in the human mglur8 gene and uses thereof | |
| EP1581614A4 (en) | Nucleotide sequences for gene regulation and methods of use thereof | |
| AU2002363938A8 (en) | Methods and use of motoneuronotropic factors | |
| AU2002229113A8 (en) | Glucose transport-related genes and uses thereof | |
| EP1407039A4 (en) | Anti-arthropod vector vaccines methods of selecting and uses thereof | |
| GB0015119D0 (en) | Methods and means for regulation of gene expression | |
| AU2001257117A1 (en) | Sitosterolemia susceptibility gene (ssg): compositions and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |